VanEck Biotech ETF
Not enough financial coverage to compute a composite score for BBH. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.vaneck.com/us/en/investments/biotech-etf-bbh
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
- IPO
- 1999
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $370.68M
- Div Yield
- 0.52%
Performance & Tape
- 52W High
- $202.91
- 52W Low
- $144.42
- 50D MA
- $186.53
- 200D MA
- $183.71
- Beta
- 0.60
- Avg Volume
- 5.99K
Get TickerSpark's AI analysis on BBH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BBH Coverage
We haven't published any research on BBH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BBH Report →